|
|
|
Funding was provided to the Newcastle upon Tyne Hospitals NHS Foundation Trust (NUTH) by the swine flu vaccine manufacturers, GSK and Baxter, to include women offered swine flu vaccination in pregnancy in the UKTIS arm of the study.
It is recognised globally that there is a pressing need for good data on maternal and longer term fetal outcomes following influenza, antiviral or vaccine exposure in pregnancy, not only in view of the likelihood that AH1N1 may remain the dominant circulating influenza strain, but also given the likelihood of other, potentially more virulent influenza outbreaks in the future.
The study is currently due to run until September 2011, shortly after data on pregnancy outcome and infant development and health at age 6 months will be available for analysis.
|
|
|
